|
|
|
Insider
Information: |
Stahl Neil |
Relationship: |
EVP Research and Devel... |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
50,999 |
|
Indirect Shares
|
10,439 |
|
|
Direct
Value |
$49,464,440 |
|
|
Indirect Value
|
$10,124,890 |
|
|
Total
Shares |
61,438 |
|
|
Total
Value |
$59,589,331 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
5
|
Stock
price went up :
|
0
|
4
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
4.0
|
Percentage
Gain/Loss : |
0.0%
|
57.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Regeneron Pharmaceuticals Inc |
REGN |
EVP Research and Devel... |
2024-02-26 |
50,999 |
2024-02-26 |
10,439 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
140 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
REGN |
Regeneron Pharmaceuticals... |
SVP Res and Dev Sciences |
|
2009-07-27 |
4 |
AS |
$20.74 |
$558,232 |
D/D |
(26,886) |
350 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Research and Development S |
|
2012-02-14 |
4 |
D |
$111.01 |
$3,210,187 |
D/D |
(28,918) |
111,405 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Res and Devel Sciences |
|
2012-11-20 |
4 |
D |
$167.17 |
$5,039,005 |
D/D |
(30,143) |
83,478 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research and Development |
|
2024-02-02 |
4 |
OE |
$399.66 |
$12,289,545 |
D/D |
30,750 |
82,769 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Research and Development S |
|
2012-02-14 |
4 |
S |
$107.83 |
$3,436,651 |
D/D |
(31,202) |
80,203 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Research and Development S |
|
2014-02-12 |
4 |
D |
$324.44 |
$10,361,316 |
D/D |
(31,936) |
47,003 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Research and Development S |
|
2013-05-10 |
4 |
D |
$268.40 |
$8,696,160 |
D/D |
(32,400) |
72,026 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Research and Development S |
|
2011-09-07 |
4 |
AS |
$67.47 |
$2,354,375 |
D/D |
(33,760) |
50,350 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Res and Dev Sciences |
|
2011-04-05 |
4 |
AS |
$45.83 |
$1,572,656 |
D/D |
(34,115) |
50,350 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research and Development |
|
2021-05-14 |
4 |
D |
$516.69 |
$18,073,300 |
D/D |
(34,979) |
41,801 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Research and Development S |
|
2014-08-06 |
4 |
OE |
$21.25 |
$743,750 |
D/D |
35,000 |
48,527 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Research and Development S |
|
2012-02-13 |
4 |
D |
$113.35 |
$4,019,844 |
D/D |
(35,464) |
90,323 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research and Development |
|
2023-08-21 |
4 |
D |
$833.39 |
$31,948,006 |
D/D |
(38,335) |
64,765 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Res & Dev Sciences |
|
2012-06-19 |
4 |
AS |
$115.60 |
$4,514,593 |
D/D |
(38,911) |
59,121 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
officerTitle |
|
2006-02-03 |
4 |
OE |
$7.41 |
$296,400 |
D/D |
40,000 |
27,127 |
|
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Research and Development S |
|
2012-08-28 |
4 |
OE |
$21.92 |
$876,800 |
D/D |
40,000 |
99,121 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP, Therap & Clin Prog Dev |
|
2006-10-31 |
4 |
AS |
$20.00 |
$834,639 |
D/D |
(41,689) |
9,647 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Research and Development S |
|
2011-09-06 |
4 |
D |
$65.76 |
$3,226,054 |
D/D |
(49,058) |
84,110 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Res and Dev Sciences |
|
2010-12-14 |
4/A |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,350 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Research and Development S |
|
2012-02-14 |
4 |
OE |
$16.80 |
$840,000 |
D/D |
50,000 |
140,323 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research and Development |
|
2023-08-21 |
4 |
OE |
$399.66 |
$19,983,000 |
D/D |
50,000 |
103,100 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research and Development |
|
2021-12-03 |
4 |
D |
$632.45 |
$31,845,122 |
D/D |
(50,352) |
50,957 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research and Development |
|
2021-05-14 |
4 |
OE |
$52.03 |
$7,815,575 |
D/D |
52,500 |
49,005 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Res and Devel Sciences |
|
2012-11-20 |
4 |
OE |
$16.80 |
$915,600 |
D/D |
54,500 |
104,219 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Research and Development S |
|
2014-02-12 |
4 |
OE |
$16.80 |
$1,094,406 |
D/D |
54,548 |
50,807 |
0 |
- |
|
140 Records found
|
|
Page 5 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|